Day: March 28, 2022

Approval of additional indication based on Phase 2b/3 SELECTION study in patients with moderate-to-severe ulcerative colitis Mechelen, Belgium; 28 March 2022, 08.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) reports that Gilead Sciences K.K. (Tokyo, Japan), Eisai Co., Ltd. (Tokyo, Japan) and EA Pharma Co., Ltd. (Tokyo, Japan) today announced the approval by the Japanese Ministry of Health, Labour and Welfare (MHLW), of a second indication for Jyseleca (filgotinib), a once-daily, oral, JAK1 preferential inhibitor, for the treatment of patients with moderate-to-severe active ulcerative colitis (UC). The approval of this second indication for Jyseleca in Japan is based on data from the randomized, double-blind, placebo-controlled phase 2b/3 SELECTION study. This study evaluated the efficacy and safety of Jyseleca for induction and maintenance...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN CORNISH METALS INC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF CORNISH METALS...

Singapore,March 28, 2022 ASM International N.V. (Euronext Amsterdam: ASM) officially unveiled its state-of-the-art Singapore manufacturing facility and operations hub today and announced the groundbreaking of a second manufacturing floor at the site. The opening ceremony was attended by Singapore Minister for Manpower and Second Minister for Trade and Industry, Dr Tan See Leng, and by representatives of JTC Corporation and of the Singapore Economic Development Board. ASM’s Singapore expansion comes amidst recent global chip shortages, and will enable ASM to capitalize on surging demand brought on by accelerated digitalization trends. The facility, including the first manufacturing floor, was completed at the end of 2020. Including the second manufacturing floor, that will be production-ready early 2023, ASM’s capacity in Singapore will...

NFL Biosciences: 2021 full-year business and earnings update Phase II/III clinical trial rolled out for the drug candidate NFL-101 for smoking cessation: first patients recruited and recruitment capacity ramped up Organization further strengthened and active ingredient manufacturing partnership set up Intellectual property extended with an NFL Biosciences patent registered in the United States Co-development agreement signed for the drug candidate NFL-301 to reduce alcohol consumption NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company that is developing botanical drugs for the treatment of addictions, is reporting its 2021 full-year earnings, approved by the Board of Directors on March 24, 2022, while looking back on its progress following its admission to Euronext Growth Paris at the start of July...

WISeKey to Present at the Maxim Group 2022 Virtual Growth Conference on March 29th Geneva – March 28, 2022 – WISeKey International Holding Ltd. (“WISeKey,” SIX: WIHN / Nasdaq: WKEY), a leading global Semi-conductor, AI and IoT company, today announced that its CEO, Carlos Moreira is scheduled to participate in fireside chat at the Maxim Group Virtual Growth Conference on Tuesday, March 29, 2022 at 9:00am ET. Conference agenda and registration details can be found at https://m-vest.com/events/2022-virtual-growth-conference. Investors interested to schedule a one-on-one virtual meeting with management, can send an email to Investor Relations at lcati@equityny.com. Mr. Moreira’s discussion will focus on presenting the method used by WISeKey to secure the authenticity and provenance of assets through cutting-edge authentication processes...